Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 10Overweight 4Obesity 4Neoplasms 4Prostatic Neoplasms 3Motor Activity 3Colorectal Neoplasms 3Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Lymphoma 2Leukemia 2Hematopoietic and Lymphoid System Neoplasm 2Hematologic Neoplasms 2Fatigue 2Colonic Neoplasms 2Breast Carcinoma In Situ 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Rectal Neoplasms 1Pancreatic Neoplasms 1Obesity-Related Malignant Neoplasm 1No Evidence of Disease 1Neoplasm Metastasis 1Metastatic Pancreatic Adenocarcinoma 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Salpingo-oophorectomy 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1High-Throughput Nucleotide Sequencing 1Genotype 1Genetic Testing 1Genetic Counseling 1Counseling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Breast and Ovarian Cancer Syndrome × Counseling × 1 year × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡